| |
Life Science Conference
|
| With Seppo Kopsala (CEO, Optomed), Renee Aguiar-Lucander (CEO, Calliditas), Carlos de Sousa (CEO, Ultimovacs), Megan Dow (Head of Corp Strategy, Biohaven), Jannik Schmidt (Head of Life Science, Innovation Norway), Jonathan Gertler (Back Bay Life Science Advisors). |
| Shearman & Sterling, 599 Lexington Ave |
|
Dec 07 (Wed) , 2022 @ 08:00 AM
| |
FREE |
|
|
|
|
|
|
|
|
| |
/-73.97083282,40.75796127,13,0,0/550x200?access_token=pk.eyJ1IjoiZ2FyeXNndWlkZSIsImEiOiJjamtobmRiYmgwb3gwM3F1a2o2Mmd0YWw3In0.DinA62CR3-OKtf3axa5O7Q)
|
| |
| DETAILS |
|
The largest Nordic-US partnering event in the US
About this event
THE 7th ANNUAL NORDIC AMERICAN LIFE SCIENCE CONFERENCE, NEW YORK CITY
Celebrating Nordic American Life Science Investment & Partnering
The most comprehensive gathering of Nordic life science innovation in the US, covering key company developments & trends from Norway, Sweden, Denmark, Finland & Iceland
The only event of its kind in the US, providing the largest US-Nordic forum in the US for life sciences, while at the same time being an intimate & highly curated gathering
Taking place over two days in New York City, the conference brings together leading Nordic biotechnology, medtech & healthtech companies & their investors for networking & connection opportunities with industry partners, innovation organizations, corporate development & investors
Hosted by DNB, Nasdaq & Business Sweden, with Back Bay Life Science Advisors & Innovation Norway, the conference is offered at no cost to our closest network of development peers - with the goal of fostering ongoing US-Nordic collaboration, investments & driving Nordic life science development forward
Presentations by leading Nordic biopharma, medtech & healthtech companies in areas with high patient need including oncology, cardiovascular, metabolic health, wound healing, & vaccines are scheduled
Expert panel discussions & workshops covering industry trends & challenges, including:
Business challenges in new technologies (CAR T, microbiome, mRNA)
Critical issues in digital healthcare development
Impact of current public markets on life science deals
Nordic equity valuations
Alternative financing, partnering trends
To learn more or to become involved with The Nordic American Life Science Conference, please reach out. We look forward to hearing from you!
VIEW PROGRAM AND VIDEOS: https://www.nordic-americanlifescience.com/
|
|
|
|
|
|
|
|
